BioSculpture Technology, Inc. Go Back to List

Market: PRIVATE | Ticker: Pending
Industry: Life Science and Healthcare
Presenting: June 15, 2017 - 2:00 PM | Breakout Room: Julliard

BioSculpture Technology, Inc. is a commercial stage medical device manufacturer developing a patented and prototyped minimally invasive procedure and device for the direct endoscopic removal of visceral or "belly" fat as a new treatment of obesity, metabolic syndrome and type 2 diabetes mellitus. We believe our method and device will save lives, improve life outcomes, and significantly reduce healthcare costs.

2/3 of the U.S. population is overweight and 43% is forecast to be obese in a few years. Obesity related disease expenditures exceeded $2 Trillion and obesity medical device expenditures exceeded $1.5 Billion in 2015. Current bariatric procedures are highly invasive, involve significant risks and life-changing compromises. And, 15% of them are revisions. There is an enormous unmet need for a minimally invasive treatment of obesity that is safer and highly effective.

The company has an qualified tier 2 Regulation A Offering to enable it to fund development and clinical testing.

Go Back to List